F8 ENT (ASX: 08347) has released its financial results for the fiscal year ended March 31, 2026. The company reported annual revenue of approximately HK$292 million, representing a decrease of 15.55% compared to the previous year.

The net loss for the period was HK$220,000, which marks a significant narrowing of 73.33% year-on-year. This resulted in a basic loss per share of HK$0.0016.